Pronouns: she/her
Email: bkelleher@purdue.edu
Phone: 765-494-6754
Office:
PSYC 1150
703 3rd Street
Bridgette Kelleher
Associate Professor, Department of Psychological Sciences
Courtesy Appointments
Department of Speech, Language, and Hearing Sciences
Areas of Expertise
- clinical psychological science
- neurodevelopmental disorders
- telehealth technology and design
- personalized health
- multidisciplinary assessment
HHS Signature Research Area(s)
- Developmental Health and Wellness
- Healthy Lifestyles and Vital Longevity
Department of Psychological Sciences Research Area(s)
- Clinical Psychological Sciences
- Neuroscience and Behavior
Biography
Dr. Bridgette Kelleher (she/her) is an associate professor of psychological sciences. She obtained her Ph.D. from the University of South Carolina (2015) after completing her APA-certified clinical residency at the Medical University of South Carolina/Charleston Consortium. Kelleher’s internationally-recognized research program focuses on optimizing clinical outcomes in “high risk” populations, with particular focus on using technology-driven solutions to assess and treat families affected by rare disorders. Her current research addresses three primary questions:
- How can remote technology be used to improve clinical monitoring of children at “high risk” for atypical development, including in the contexts of natural history studies and clinical trials?
- How can remotely collected “real world” data be used to improve personalized interventions?
- How can clinical research better center patient and community perspectives?
Kelleher works with a variety of communities to address these questions, including children with rare neurogenetic syndromes and their families. Her research has been supported through a variety of active research grants funded by the National Institutes of Health, Angelman Syndrome Foundation, Foundation for Prader Willi Research, and Williams Syndrome Association. More information about these and other projects can be found on the Kelleher Lab web site and social media channels.
Dr. Kelleher may be recruiting for Fall 2025 cycle. Please contact her directly to confirm.
Education
- PhD, 2015, University of South Carolina
Websites
Social Media Accounts
Diversity, Equity and Inclusion
- Member, Clinical Psychology DEI Committee
Selected Grants
- [Pending NOA] Principal Investigator, Optimizing a Personalized Health Approach for Virtually Treating High-Risk Caregivers during COVID-19 and Beyond. National Institute of Child Health and Human Development (R01HD105502). Period: 5/1/23-4/30/25. Total: $2,980,002 (anticipated)
- Principal Investigator, Validating a Scalable, Open Science Framework for Collecting Laboratory-Grade Data Remotely in Specialized Populations. National Institute of Child Health and Human Development (R21HD106701). Period: 9/1/21-8/31/23. Total: $420,244
- Principal Investigator, The Influence of Health Behaviors and Social Support on Mental Health Treatment Uptake among High-Risk Caregivers during COVID-19. Period: 2/10/22-2/9/23. Total: $15,000
- Principal Investigator with MPIs Dan Foti and Kelly LeMaire, Caregiver Well-Being in Prader Willi Syndrome and Williams Syndrome. Foundation for Prader Willi Research and Williams Syndrome Association (jointly funded). Period: 10/1/21-9/30/22. Total: $56,700 (FPWR), $37,500 (WSA)
- Principal Investigator with MPIs Anita Panjwani, Regan Bailey, Steve Lindemann. Ingestive Behaviors and Gut Microbiota in Angelman Syndrome. Period: 10/1/21-12/31/22 (with NCE). Total: $100,000
In the News
- Purdue Psychological Sciences Research to Streamline Telehealth for Caregivers of Young Patients with Rare Neurogenetic Syndromes
- Virtual lab visits enable remote assessment of child development (Spectrum News, October 7, 2020)
- Kids staying home due to extended school breaks or closings? Here are some fun activities for your family (WLFI, March 20, 2020)
- Behaviors in children with autism spectrum disorder increased during COVID-19, experts say (Journal & Courier, June 25, 2021)
- Remote tools may offer personalized autism treatments (Purdue News, March 23, 2020)